Möchten Sie immer auf dem neuesten Stand bleiben?

BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today...

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today...

Developed with DP World and CPKC, the facility integrates maritime and rail access to streamline global movement of temperature-controlled products

BEAM-304 Development Approach Has Potential to Create Transformative, One-time Therapies for the Majority of Patients with PKU  BEAM-304 Program Designed as Platform-based Approach Reflecting...

Roasting Plant® Coffee, today announced a major new phase of international growth, building on recent U.S. expansion and a newly signed licensing agreement

Austin, June 18, 2026 (GLOBE NEWSWIRE) -- The Engineered Quartz Surface Market was valued at USD 17.09 Billion in 2025 and is expected to reach USD 36.80 Billion by 2035, growing at a CAGR of 8.07%...

Austin, June 18, 2026 (GLOBE NEWSWIRE) -- The Rigid Foam Market was valued at USD 85.43 Billion in 2025 and is expected to reach USD 200.43 Billion by 2035, growing at a CAGR of 8.9% from 2026–2035....

Press Release Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470 Exclusive licensee for China, Ocumension, received positive pre-submission...

Filing acceptance based on data from the phase III SUNMO study where subcutaneous Lunsumio VELO plus Polivy demonstrated a 59% reduction in risk of disease progression or death1 People with relapsed...

The study achieved the primary endpoint of non-inferiority, with a rate of all-cause mortality (ACM) at Day 42 for olorofim of 23.8% and for AmBisome® followed by standard of care of 24.3% No new...